Page 4 - Cell Program News Today

Ginkgo added 21 new Cell Programs to the Foundry platform in Q3 2023 Entered into strategic cloud and AI partnership with Google Cloud; first milestone recently achieved Signed new multi-target RNA...

Statements in the following discussion and throughout this report that are not historical in nature are forward-looking statements. You can identify forward-looking statements by the use of words such... | March 30, 2023

The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow transplant programs in the U.S.

Regulatory News: MedinCell (Paris:MEDCL): Revenue: €7.7 million (+89% compared to the first half of the previous year) Operating expenses: €19.4 million (+27% compared to the first half of

10.11.2022 - INB-100 continued to demonstrate durable morphologic complete responses in the Phase 1 clinical trial in patients with leukemia; on track to announce additional data at upcoming ASH annual meeting.Partnered with the Dunbar CAR T-Cell Program at the ...

INB-100 continued to demonstrate durable morphologic complete responses in the Phase 1 clinical trial in patients with leukemia; on track to announce...

IN8bio (NASDAQ:INAB) chief financial officer Patrick McCall takes Proactives Stephen Gunnion through the clinical-stage biopharmaceutical...

Agreement provides exclusive access to state-of-the-art GMP manufacturing suites to support Phase 2 clinical studiesPotential to expand the agreement to...

IN8bio Partners with the Dunbar CAR T-Cell Program at the University of Louisville as the Manufacturing Center for INB-400 - read this article along with other careers information, tips and advice on BioSpace

Scientific explanation on benefits of Fasting/Caloric restriction.